European Archives of Oto-Rhino-Laryngology

, Volume 268, Issue 12, pp 1735–1741 | Cite as

Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases

  • Yalcin Alimoglu
  • Ender Inci
  • Deniz Tuna Edizer
  • Alper Ozdilek
  • Mehmet Aslan
Otology

Abstract

Idiopathic sudden sensorineural hearing loss is a rare disorder of unknown pathogenesis in which hearing is lost partially or totally. About 60 treatment modalities have been described. We aimed to compare the efficacy of hyperbaric oxygen, oral steroid, intratympanic steroid therapy and their combinations in idiopathic sudden sensorineural hearing loss patients. Files of patients who were followed up between 2004 and 2010 in our clinic were examined retrospectively. Patients were divided into four groups according to the therapy received: Oral steroid, oral steroid + hyperbaric oxygen, intratympanic steroid and hyperbaric oxygen. Treatment success was assessed by Siegel criteria and mean gains using pre-treatment and post-treatment audiograms. 217 patients and 219 ears were examined. The proportion of patients responding to therapy was the highest in the oral steroid + hyperbaric oxygen group with 86.88% (53/61) followed by the oral steroid group with 63.79% (37/58), the intratympanic steroid group with 46,51% (20/43) and the hyperbaric oxygen group with 43.85% (25/57). The proportion of patients who had complete recovery was the highest in the oral steroid + hyperbaric oxygen group with 42.6% (26/61) followed by the oral steroid group with 19.0% (11/58), the hyperbaric oxygen group with 17.5% (10/57) and the intratympanic steroid group with 11.6% (5/43). The oral steroid + hyperbaric oxygen group has the highest mean hearing gain among all groups (p < 0.05). Idiopathic sudden sensorineural hearing loss patients receiving oral steroid + hyperbaric oxygen combination therapy have a higher likelihood of recovery than patients receiving oral steroids, hyperbaric oxygen or intratympanic steroids alone.

Keywords

Sudden hearing loss Sensorineural hearing loss Hyperbaric oxygen therapy Steroids Intratympanic 

Notes

Conflicts of interest

Authors declare no conflict of interest.

References

  1. 1.
    National Institute of Health. Sudden Deafness. Bethesda, Md: National Institutes of Health; 2000. NIH publication 00-4757Google Scholar
  2. 2.
    Gianoli GJ, Li JC (2001) Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Had Neck Surg 125(3):142–146CrossRefGoogle Scholar
  3. 3.
    Battaglia A, Burchette R, Cueva R (2008) Combination therapy intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29(4):453–460PubMedCrossRefGoogle Scholar
  4. 4.
    Byl FM Jr (1984) Sudden hearing loss: 8 years’ experience and suggested prognostic table. Laryngoscope 94(5 Pt 1):647–661PubMedGoogle Scholar
  5. 5.
    Mattox DE, Simmons FB (1977) Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86(4 Pt 1):463–480PubMedGoogle Scholar
  6. 6.
    Klemm E, Deutscher A, Mösges R (2009) A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss. Laryngorhinootologie 88(8):524–527PubMedCrossRefGoogle Scholar
  7. 7.
    Teranishi M, Katayama N, Uchida Y, Tominaga M, Nakashima T (2007) Thirty-year trends in sudden deafness from four nationwide epidemiological surveys in Japan. Acta Otolaryngol 127(12):1259–1265PubMedCrossRefGoogle Scholar
  8. 8.
    Shaia FT, Sheehy JL (1976) Sudden sensori-neural hearing impairment: a report of 1,220 cases. Laryngoscope 86(3):389–398PubMedCrossRefGoogle Scholar
  9. 9.
    Hughes GB, Freedman MA, Haberkamp TJ, Guay ME (1996) Sudden sensorineural hearing loss. Otolaryngol Clin North Am 29(3):393–405PubMedGoogle Scholar
  10. 10.
    Oh JH, Park K, Lee SJ, Shin YR, Choung YH (2007) Bilateral versus unilateral sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 136(1):87–91PubMedCrossRefGoogle Scholar
  11. 11.
    Rauch SD (2008) Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 359(8):833–840PubMedCrossRefGoogle Scholar
  12. 12.
    Siegel LG (1975) The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 8(2):467–473PubMedGoogle Scholar
  13. 13.
    García Berrocal JR, Ramírez-Camacho R (2000) Immune response and immunopathology of the inner ear: an update. J Laryngol Otol 114(2):101–107PubMedGoogle Scholar
  14. 14.
    Mort DJ, Bronstein AM (2006) Sudden deafness. Curr Opin Neurol 19(1):1–3PubMedCrossRefGoogle Scholar
  15. 15.
    Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 106(12):772–776PubMedGoogle Scholar
  16. 16.
    Cinamon U, Bendet E, Kronenberg J (2001) Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol 258:477–480PubMedCrossRefGoogle Scholar
  17. 17.
    Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss: I A systematic review. Arch Otolaryngol Head Neck Surg 133(6):573–581PubMedCrossRefGoogle Scholar
  18. 18.
    Moskowitz D, Lee KJ, Smith HW (1984) Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 94(5 Pt 1):664–666PubMedGoogle Scholar
  19. 19.
    Fetterman BL, Saunders JE, Luxford WM (1996) Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 17(4):529–536PubMedGoogle Scholar
  20. 20.
    Kanzaki J, Taiji H, Ogawa K (1988) Evaluation of hearing recovery and efficacy of steroid treatment in sudden deafness. Acta Otolaryngol Suppl 456:31–36PubMedCrossRefGoogle Scholar
  21. 21.
    Kubo T, Matsunaga T, Asai H, Kawamoto K, Kusakari J, Nomura Y, Oda M, Yanagita N, Niwa H, Uemura T et al (1988) Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg 114(6):649–652PubMedGoogle Scholar
  22. 22.
    Cavallazzi GM (1996) Relations between O2 and hearing function. İn: Marroni A, Oriani G, Wattel F (eds) Proceedings of international joint meeting on hyperbaric and underwater medicine, Milano (Italy), pp 633–645, September 4–8Google Scholar
  23. 23.
    Nagahara K, Fisch K, Yagi M (1983) Perilymph oxygenation in sudden and progressive sensorineural hearing loss. Acta Otolaryngol 96:57–69PubMedCrossRefGoogle Scholar
  24. 24.
    Tsunoo M, Perlman MB (1960) Temporary arterial obstruction. Effects on perilymph oxygen and microphonics. Acta Otolaryngol 67:460–466CrossRefGoogle Scholar
  25. 25.
    Fattori B, Berrettini S, Casani A, Nacci A, De Vito A, De Iaco G (2001) Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study. Ear Nose Throat J 80(9):655–660PubMedGoogle Scholar
  26. 26.
    Cekin E, Cincik H, Ulubil SA, Gungor A (2009) Effectiveness of hyperbaric oxygen therapy in management of sudden hearing loss. J Laryngol Otol 123(6):609–612PubMedCrossRefGoogle Scholar
  27. 27.
    Aslan I, Oysu C, Veyseller B, Baserer N (2002) Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg 126(2):121–126PubMedCrossRefGoogle Scholar
  28. 28.
    Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T (2007) Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 264(8):861–866PubMedCrossRefGoogle Scholar
  29. 29.
    Topuz E, Yigit O, Cinar U, Seven H (2004) Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol 261(7):393–396PubMedCrossRefGoogle Scholar
  30. 30.
    Inci E, Erişir F, Ada M, Oztürk O, Güçlü E, Oktem F, Toprak M (2002) Hyperbaric oxygen treatment in sudden hearing loss after unsuccessful medical treatment. Kulak Burun Bogaz Ihtis Derg 9(5):337–341PubMedGoogle Scholar
  31. 31.
    Chandrasekhar SS (2001) Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22(1):18–23PubMedCrossRefGoogle Scholar
  32. 32.
    Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT (2004) Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 114(7):1184–1189PubMedCrossRefGoogle Scholar
  33. 33.
    Fitzgerald DC, McGuire JF (2007) Intratympanic steroids for idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 116:253–256PubMedGoogle Scholar
  34. 34.
    Alles MJ, der Gaag MA, Stokroos RJ (2006) Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol 263(9):791–797PubMedCrossRefGoogle Scholar
  35. 35.
    Kara E, Cetik F, Tarkan O, Sürmelioğlu O (2010) Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 267(5):701–707PubMedCrossRefGoogle Scholar
  36. 36.
    Hong M, Park CH, Lee JH (2009) Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg 141(5):579–583PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Yalcin Alimoglu
    • 1
  • Ender Inci
    • 1
  • Deniz Tuna Edizer
    • 1
  • Alper Ozdilek
    • 1
  • Mehmet Aslan
    • 1
  1. 1.Cerrahpasa Medical Faculty, Otolaryngology DepartmentIstanbul UniversityIstanbulTurkey

Personalised recommendations